Skip to main content
NASDAQ:FRLN

Freeline Therapeutics Short Interest Ratio and Short Volume

$8.75
-0.24 (-2.67 %)
(As of 05/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.75
$9.75
50-Day Range
$8.74
$14.41
52-Week Range
$8.31
$21.69
Volume40,813 shs
Average Volume9,769 shs
Market Capitalization$313.73 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Short Interest

Freeline Therapeutics (NASDAQ:FRLN) Short Interest Data

Current Short Volume29,800 shares
Previous Short Volume29,500 shares
Change Vs. Previous Month+1.02%
Dollar Volume Sold Short$359,090.00
Short Interest Ratio / Days to Cover0.0
Last Record DateApril, 15 2021
Outstanding Shares35,855,000 shares
Percentage of Shares Shorted0.08%
Today's Trading Volume40,813 shares
Average Trading Volume9,769 shares
Today's Volume Vs. Average317.78%

Short Interest Over Time


Freeline Therapeutics (NASDAQ:FRLN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202129,800 shares $359,090.00 +1.0%N/A0$12.05
3/31/202129,500 shares $392,055.00 -9.0%0.1%3.3$13.29
3/15/202132,400 shares $456,516.00 +7.3%0.1%3.4$14.09
2/26/202130,200 shares $456,926.00 +6.3%0.1%2.5$15.13
2/12/202128,400 shares $429,408.00 -8.4%0.1%2.3$15.12
1/29/202131,000 shares $550,246.90 -61.1%0.1%2.1$17.75
1/15/202179,700 shares $1.43 million No Change0.2%4.9$18.00

Freeline Therapeutics (NASDAQ:FRLN) Short Interest FAQ

speech bubbles
speech bubbles











What is Freeline Therapeutics' current short interest?

Short interest is the volume of Freeline Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 29,800 shares of FRLN short.

Is Freeline Therapeutics' short interest increasing or decreasing?

Freeline Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 29,800 shares, an increase of 1.0% from the previous total of 29,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Freeline Therapeutics' short interest compare to its competitors?

0.00% of Freeline Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Freeline Therapeutics: Atara Biotherapeutics, Inc. (0.00%), Alector, Inc. (10.91%), Translate Bio, Inc. (0.00%), Curis, Inc. (0.00%), Forma Therapeutics Holdings, Inc. (9.85%), Coherus BioSciences, Inc. (19.69%), Cortexyme, Inc. (26.33%), Vaxcyte, Inc. (13.33%), Scholar Rock Holding Co. (8.09%), and Black Diamond Therapeutics, Inc. (17.30%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Freeline Therapeutics stock?

Short selling FRLN is an investing strategy that aims to generate trading profit from Freeline Therapeutics as its price is falling. Freeline Therapeutics' stock is trading down $0.24 today. To short Freeline Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Freeline Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Freeline Therapeutics?

A short squeeze for Freeline Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FRLN, which in turn drives the price of the stock up even further.

How often is Freeline Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FRLN, twice per month. The most recent reporting period available is April, 15 2021.



This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.